JA
EXEL icon

JLB & Associates’s Exelixis EXEL Stock Holding History

JLB & Associates’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
+48,849
New +$2.38M 0.36% 47

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JLB & Associates's EXEL Position: Q2 2026 in Review

JLB & Associates opened a new position in Exelixis (EXEL) in Q2 2026: 48,849 shares worth $2.66M. The stake represents 0.36% of the portfolio and ranks #47 among its holdings.

756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • JLB & Associates held 48,849 shares of Exelixis worth $2.66M as of Q2 2026.
  • Exelixis was a new JLB & Associates position in Q2 2026.
  • Exelixis made up 0.36% of JLB & Associates's portfolio in Q2 2026, its #47 holding.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on JLB & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.